agilon health (NYSE:AGL) Announces Quarterly Earnings Results

agilon health (NYSE:AGL) issued its quarterly earnings data on Tuesday. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.18) by ($0.07), Zacks reports. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%.

agilon health Trading Up 1.8 %

AGL stock traded up $0.07 during midday trading on Tuesday, hitting $3.71. The stock had a trading volume of 6,725,137 shares, compared to its average volume of 5,298,555. agilon health has a 12-month low of $1.50 and a 12-month high of $7.73. The company’s 50-day moving average price is $2.85 and its 200 day moving average price is $3.05. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The firm has a market cap of $1.53 billion, a PE ratio of -3.94 and a beta of 0.66.

Insider Activity at agilon health

In related news, Director Karen Mcloughlin bought 25,000 shares of the stock in a transaction that occurred on Friday, December 13th. The stock was purchased at an average cost of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the acquisition, the director now owns 73,166 shares in the company, valued at $160,965.20. This trade represents a 51.90 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director John William Wulf purchased 45,000 shares of the firm’s stock in a transaction on Thursday, December 5th. The stock was bought at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the acquisition, the director now owns 206,133 shares in the company, valued at $449,369.94. The trade was a 27.93 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders acquired 77,500 shares of company stock worth $169,600. 3.20% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on AGL shares. Macquarie started coverage on agilon health in a research note on Monday, December 16th. They set a “neutral” rating and a $3.00 price target on the stock. Needham & Company LLC started coverage on shares of agilon health in a research report on Friday, January 10th. They set a “hold” rating on the stock. William Blair cut shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Citigroup upgraded shares of agilon health from a “sell” rating to a “neutral” rating and increased their price target for the stock from $1.75 to $2.25 in a research note on Friday, January 10th. Finally, Barclays dropped their price objective on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research note on Monday, November 11th. Two research analysts have rated the stock with a sell rating, fourteen have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $4.03.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.